The role of BTK inhibitors in the treatment of MCL: ongoing trials and future outlooks VJHemOnc – Video Journal of Hematology & HemOnc 6:35 3 months ago 234 Далее Скачать
Selecting between BTK inhibitors in MCL & addressing resistance to these agents VJHemOnc – Video Journal of Hematology & HemOnc 2:48 4 months ago 142 Далее Скачать
An overview of clinical trials investigating BTK inhibitors and degraders in MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:22 2 weeks ago 77 Далее Скачать
Selecting BTK inhibitors for patients with MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:32 1 year ago 192 Далее Скачать
Identifying Differences Between BTK Inhibitors for B-Cell Malignancies Targeted Oncology 1:00 4 years ago 151 Далее Скачать
BTK inhibitors for R/R MCL: current uses and insights from the ViPOR study VJHemOnc – Video Journal of Hematology & HemOnc 2:40 1 year ago 152 Далее Скачать
Optimizing Treatment Pathways in CLL and MCL: Evaluating and Applying Recent Data on BTK Inhibitors Medscape 36:55 4 months ago 13 Далее Скачать
Solving the Puzzles for B-Cell Malignancies: Navigating the Place of BTK Inhibitors Today and Tom... Medscape 1:32:21 4 months ago 6 Далее Скачать
The role of covalent and non-covalent BTKIs in the MCL treatment landscape VJHemOnc – Video Journal of Hematology & HemOnc 2:38 4 months ago 87 Далее Скачать
Cardiovascular adverse events following treatment with BTK inhibitors in CLL & MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:21 1 year ago 203 Далее Скачать